Genmab A/s
(OTC) GNMSF
Genmab A/s Financials at a Glance
Market Cap
$16.93B
Revenue (TTM)
$18.73B
Net Income (TTM)
$4.05B
EPS (TTM)
$15.43
P/E Ratio
17.67
Dividend
$0.00
Beta (Volatility)
0.36 (Low)
Dividend
$0.00
Beta (Volatility)
0.36 (Low)
Price
$274.75
Volume
56
Open
$274.75
Price
$274.75
Volume
56
Open
$274.75
Previous Close
$274.75
Daily Range
$274.75 - $274.75
52-Week Range
$170.00 - $352.00
Dividend
$0.00
Beta (Volatility)
0.36 (Low)
Price
$274.75
Volume
56
Open
$274.75
Previous Close
$274.75
Daily Range
$274.75 - $274.75
52-Week Range
$170.00 - $352.00
GNMSF News
GNMSF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genmab A/s
Industry
Biotechnology
Sector
Health CareEmployees
3,029
CEO
Jan G. J. van de Winkel, PhD
Website
www.genmab.comHeadquarters
Copenhagen, 1560, DK
GNMSF Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
33%
Net Income Margin
17%
Return on Equity
18%
Return on Capital
11%
Return on Assets
5%
Earnings Yield
5.66%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$16.93B
Shares Outstanding
61.63M
Volume
56
Short Interest
0.00%
Avg. Volume
1.52K
Financials (TTM)
Gross Profit
$22.51B
Operating Income
$8.25B
EBITDA
$8.72B
Operating Cash Flow
$7.83B
Capital Expenditure
$244.13M
Free Cash Flow
$7.58B
Cash & ST Invst.
$10.88B
Total Debt
$35.28B
Genmab A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.77B
+5.2%
Gross Profit
$6.25B
+2.5%
Gross Margin
92.34%
N/A
Market Cap
$16.93B
N/A
Market Cap/Employee
$6.42M
N/A
Employees
2,638
N/A
Net Income
$198.46M
-94.8%
EBITDA
$1.56B
-33.9%
Quarterly Fundamentals
Net Cash
$24.40B
-221.5%
Accounts Receivable
$7.31B
+9.2%
Inventory
$114.21M
+84.2%
Long Term Debt
$33.43B
+3468.1%
Short Term Debt
$1.85B
+1907.0%
Return on Assets
4.95%
N/A
Return on Invested Capital
11.13%
N/A
Free Cash Flow
$1.84B
-29.6%
Operating Cash Flow
$1.93B
-28.9%